Soleus Capital Discloses Significant Stake in Cerus Corp via 13G Filing
| Field | Detail |
|---|---|
| Company | Schedule 13g - Soleus Capital Master Fund, L.P. (0001812275) (Filed By) |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: insider-buy, institutional-ownership, 13G-filing
TL;DR
**Soleus Capital just revealed a big stake in CERUS CORP, signaling a potential bullish move.**
AI Summary
Soleus Capital Master Fund, L.P. filed a Schedule 13G on March 24, 2026, indicating its beneficial ownership in CERUS CORP. This filing, required when an investor acquires more than 5% of a company's stock, signals that Soleus Capital now holds a significant stake in CERUS CORP. For existing or potential shareholders, this matters because a large institutional investor taking a substantial position can be seen as a vote of confidence, potentially influencing stock price positively due to increased demand or perceived value.
Why It Matters
A major investment fund, Soleus Capital, has publicly disclosed a significant ownership stake in CERUS CORP, which could signal confidence in the company's future and potentially attract other investors.
Risk Assessment
Risk Level: low — This filing indicates a new significant investor, which is generally a positive or neutral development for existing shareholders.
Analyst Insight
A smart investor would research Soleus Capital's investment history and CERUS CORP's fundamentals to understand the rationale behind this significant stake, potentially considering CERUS CORP as a buy if the underlying business outlook is strong.
Key Players & Entities
- Soleus Capital Master Fund, L.P. (company) — the entity filing the Schedule 13G
- CERUS CORP (company) — the subject company in which Soleus Capital holds a stake
- March 24, 2026 (date) — the filing date of the Schedule 13G
- 0001812275 (person) — CIK of Soleus Capital Master Fund, L.P.
- 0001020214 (person) — CIK of CERUS CORP
Forward-Looking Statements
- The stock price of CERUS CORP may experience a positive reaction due to increased investor confidence. (CERUS CORP) — medium confidence, target: Within the next 3 months
FAQ
What type of filing did Soleus Capital Master Fund, L.P. submit?
Soleus Capital Master Fund, L.P. submitted a SCHEDULE 13G, which is a Statement of Beneficial Ownership by Certain Investors.
When was this Schedule 13G filing made?
The Schedule 13G filing was made on March 24, 2026, and was accepted on the same date at 16:45:53.
Which company is the subject of Soleus Capital Master Fund, L.P.'s beneficial ownership?
The subject company is CERUS CORP, identified by CIK 0001020214.
What is the SIC code for CERUS CORP?
CERUS CORP's SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What is the business address listed for Soleus Capital Master Fund, L.P. in this filing?
The business address for Soleus Capital Master Fund, L.P. is 104 FIELD POINT ROAD, 2ND FLOOR, GREENWICH CT 06830.
Filing Stats: 341 words · 1 min read · ~1 pages · Grade level 13.9 · Accepted 2026-03-24 16:45:53
Filing Documents
- primary_doc.html (SCHEDULE 13G)
- primary_doc.xml (SCHEDULE 13G) — 18KB
- ea028320201ex99-a.htm (EX-99.A) — 12KB
- 0001213900-26-033591.txt ( ) — 32KB
From the Filing
EX-99.A 2 ea028320201ex99-a.htm JOINT FILING AGREEMENT Exhibit 99.A EXHIBIT A Joint Filing Agreement Soleus Capital Master Fund, L.P., a Cayman Islands exempted limited partnership, Soleus Capital, LLC, a Delaware limited liability company, Soleus Capital Group, LLC, a Delaware limited liability company, Soleus Capital Management, L.P., a Delaware limited partnership, Soleus GP, LLC, a Delaware limited liability company, and Guy Levy, an individual, hereby agree to file jointly the statement on Schedule 13G to which this Joint Filing Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934, as amended. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate. It is understood and agreed that a copy of this Agreement shall be attached as an exhibit to the statement on Schedule 13G, and any amendments hereto, filed on behalf of each of the parties hereto. Date : March 24, 2026 Soleus Capital Master Fund, L.P. By: Soleus Capital, LLC, its General Partner By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : March 24, 2026 Soleus Capital, LLC By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : March 24, 2026 Soleus Capital Group, LLC By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : March 24, 2026 Soleus Capital Management, L.P. By: Soleus GP, LLC, its General Partner By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date: March 24, 2026 Soleus GP, LLC By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : March 24, 2026 /s/ Guy Levy Name: Guy Levy